A pan-cancer analysis revealed that compared to normal tissues, significantly elevated mRNA expression levels of FAM72A were observed in 82% of cancers, including BLCA, BRCA, CESC, CHOL, COAD, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LIHC, LUSC, LUAD, PCPG, PRAD, READ, SARC, STAD, and UCES. This evidence concerns the gene FAM72A and cancer.